Filed: 2/14/2024ACC: 0001104659-24-023717
📋 What this filing means
NORTHPOND VENTURES, LLC filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $21.02M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$21.02M
Total AUM (reported)
15.99M
Total Shares
Allocation by class
COM$21.02M100.0%
Portfolio Concentration
Top 3$21.02M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 15.99M
Sole
Full voting authority
15.99M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
VIGIL NEUROSCIENCE INC
SOLEShares4.21M
TypeSH
Market value$14.25M
67.78%
Sole
4.21M
Shared
0.00
None
0.00
TELESIS BIO INC
SOLEShares9.84M
TypeSH
Market value$3.93M
18.69%
Sole
9.84M
Shared
0.00
None
0.00
CANDEL THERAPEUTICS INC
SOLEShares1.94M
TypeSH
Market value$2.84M
13.54%
Sole
1.94M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VIGIL NEUROSCIENCE INCSOLE | COM | 4.21M | SH | $14.25M 67.78% | 4.21M | 0.00 | 0.00 |
TELESIS BIO INCSOLE | COM | 9.84M | SH | $3.93M 18.69% | 9.84M | 0.00 | 0.00 |
CANDEL THERAPEUTICS INCSOLE | COM | 1.94M | SH | $2.84M 13.54% | 1.94M | 0.00 | 0.00 |